Skip to main content

Lymphoproliferative Disorders

  • Chapter
  • First Online:
Mediastinal Pathology
  • 1549 Accesses

Abstract

Primary lymphoproliferative tumors of the mediastinum, similarly to their counterparts in the lymph nodes, have undergone significant changes over the last decade. These changes have been not only in terms of classification but also in terms of new approaches regarding their diagnosis. Needless to say, particularly in the mediastinum, the significant developments in our understanding of these tumors have modified older concepts and terms that may have created confusion in the literature. Terms such as granulomatous thymoma have been correctly reinterpreted as Hodgkin’s lymphoma and in turn have provided significant changes in the treatment and survival of these patients. In this chapter we will focus our discussion in those tumors occurring in the mediastinum. In addition, the chapter will be presented from the practical point of view for the practicing pathologist who may be called upon to interpret these lesions. In cases in which the utility of more advanced studies is needed, specific mention of it will be made. However, the chapter will focus more on the histopathological and immunohistochemical approach to mediastinal lymphoproliferative lesions. In addition, it is important to highlight that the focus will be on primary mediastinal lymphomas and not on the involvement of the mediastinum by lymphoma as a systemic disease. This chapter will discuss non-Hodgkin’s lymphoma (large B-cell lymphoma/primary mediastinal B-cell lymphoma, gray zone lymphoma, anaplastic large cell lymphoma, MALT lymphoma), lymphoblastic lymphoma, Hodgkin’s lymphoma, dendritic cell tumors, plasmacytoma, Castleman’s disease, and extramedullary hematopoiesis (as mediastinal tumor).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Remigio PA. Granulomatous thymoma associated with erythroid hyperplasia. Am J Clin Pathol. 1971;55:68–72.

    CAS  PubMed  Google Scholar 

  2. Strickler JG, Kurtin PJ. Mediastinal lymphoma. Semin Diagn Pathol. 1991;8:2–13.

    CAS  PubMed  Google Scholar 

  3. Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, et al. Non-Hodgkin’s lymphomas. Clinicopathologic correlation of 405 cases. Cancer. 1973;31:806–23.

    CAS  PubMed  Google Scholar 

  4. Chabner BA, Johnson RE, Young RC, Canellos GP, Hubbard SP, Johnson SK, et al. Sequential non-surgical and surgical staging of non-Hodgkin’s lymphoma. Ann Intern Med. 1976;85:149–54.

    CAS  PubMed  Google Scholar 

  5. Manoharan A, Pitney WR, Schonell ME, Bader LV. Intrathoracic manifestations in non-Hodgkin’s lymphoma. Thorax. 1979;34:29–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Goffinet DR, Warnke R, Dunnick NR, Castellino R, Glatstein E, Nelsen TS, et al. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin’s lymphoma. Cancer Treat Rep. 1977;61:981–92.

    CAS  PubMed  Google Scholar 

  7. Lukes RJ, Butler JJ, Hicks EB. Natural history of Hodgkin’s disease as related to its pathological picture. Cancer. 1966;19:317–44.

    Google Scholar 

  8. Colby TV, Hoppe RT, Warnke RA. Hodgkin’s disease: a clinicopathologic study of 659 cases. Cancer. 1981;49:1848–58.

    Google Scholar 

  9. Lichtenstein AK, Levine A, Taylor CR, Boswell W, Rossman S, Feinstein DI, et al. Primary mediastinal lymphoma in adults. Am J Med. 1980;68:509–14.

    CAS  PubMed  Google Scholar 

  10. Benjamin SP, McCormack LJ, Effler DB, Groves LK. Primary lymphatic tumors of the mediastinum. Cancer. 1972;30:708–12.

    CAS  PubMed  Google Scholar 

  11. Al-Naaman YD, Al-Ani M, Al-Omeri M. Primary mediastinal tumours. Thorax. 1974;29:475–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Adkins RB, Maples MD, Hainsworth JD. Primary malignant mediastinal tumors. Ann Thorac Surg. 1984;38:648–59.

    PubMed  Google Scholar 

  13. Glick RD, La Quaglia MP. Lymphomas of the anterior mediastinum. Semin Pediatr Surg. 1999;8:69–77.

    CAS  PubMed  Google Scholar 

  14. Suster S. Primary large cell lymphomas of the mediastinum. Semin Diagn Pathol. 1999;16:51–64.

    CAS  PubMed  Google Scholar 

  15. Petersdorf SH, Wood DE. Lymphoproliferative disorders presenting as mediastinal neoplasms. Semin Thorac Cardiovasc Surg. 2000;12:290–300.

    CAS  PubMed  Google Scholar 

  16. Barth TFE, Leithauser F, Joos S, Bentz M, Möller P. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol. 2002;3:229–34.

    PubMed  Google Scholar 

  17. Faris JE, LaCasce AS. Primary mediastinal large B-cell lymphoma. Clin Adv Hematol Oncol. 2009;7:125–33.

    PubMed  Google Scholar 

  18. Martelli M, di Rocco A, Russo E, Perrone S, Foà R. Primary mediastinal lymphoma: diagnosis and treatment options. Exp Rev Hematol. 2015;8(2):173–86.

    CAS  Google Scholar 

  19. Bhatt VR, Mourya R, Shrestha R, Armitage JO. Primary mediastinal large B-cell lymphoma. Cancer Treat Rev. 2015;41:476–85.

    PubMed  Google Scholar 

  20. Aggarval R, Rao S, Dhawan S, Bhalla S, Kumar A, Chopra P. Primary mediastinal lymphomas, their morphological features and comparative evaluation. Lung India. 2017;34:19–24.

    Google Scholar 

  21. Liu PP, Wang KF, Xia Y, Bi XW, Sun P, Wang Y, et al. Racial patterns of patients with primary mediastinal large B-cell lymphoma. Medicine. 2016;95:27(e4054).

    Google Scholar 

  22. Maeshima AM, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N, et al. Distribution of malignant lymphomas in the anterior mediastinum: a single institution study of 76 cases in Japan 1997-2016. Int J Hematol. 2017;106:675–80.

    PubMed  Google Scholar 

  23. Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PWM. Primary mediastinal B-cell lymphoma. Crit Rev Oncol Hematol. 2017;113:318–27.

    PubMed  Google Scholar 

  24. Zinzani PL, Piccaluga PP. Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies. Curr Oncol Rep. 2011;13:407–15.

    PubMed  Google Scholar 

  25. Trump DL, Mann RB. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostic subset of patients with non-Hodgkin’s lymphoma. Cancer. 1982;50:277–82.

    CAS  PubMed  Google Scholar 

  26. Levitt LJ, Aisenberg AC, Harris NL, Linggood RM, Poppema S. Primary non-Hodgkin’s lymphoma of the mediastinum. Cancer. 1982;50:2486–92.

    CAS  PubMed  Google Scholar 

  27. Yousem SA, Weiss LM, Warnke RA. Primary mediastinal non-Hodgkin’s lymphomas: a morphologic and immunologic study of 19 cases. Am J Clin Pathol. 1985;83:676–80.

    CAS  PubMed  Google Scholar 

  28. Waldrom JA, Dohring EJ, Farber LR. Primary large cell lymphoma of the mediastinum: an analysis of 20 cases. Semin Diagn Pathol. 1985;2:282–95.

    Google Scholar 

  29. Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol. 1986;10:176–91.

    CAS  PubMed  Google Scholar 

  30. Menestrina F, Chilosi M, Bonetti F, Lestani M, Scarpa A, Novelli P, et al. Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology. 1986;10:589–600.

    CAS  PubMed  Google Scholar 

  31. Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin. Histopathology. 1986;10:379–90.

    CAS  PubMed  Google Scholar 

  32. Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, et al. Large cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993;11:1336–43.

    CAS  PubMed  Google Scholar 

  33. Abou-Elella AA, Weisenburger DD, Vose JM, Kollath JP, Lynch JC, Bast MA, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska lymphoma study group. J Clin Oncol. 1999;17:784–90.

    CAS  PubMed  Google Scholar 

  34. Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay MF, Baumelou E, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphoma, a GELA (“Groupe d’Etude des Lymphomes de l’Adulte”). Am J Surg Pathol. 1996;20:877–88.

    CAS  PubMed  Google Scholar 

  35. Paulli M, Strater J, Gianelli U, Rousset M-T, Gambacorta M, Orlandi E, et al. Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases. Hum Pathol. 1999;30:178–87.

    CAS  PubMed  Google Scholar 

  36. Piira T, Perkins SL, Anderson AT, Meadows AT, Chilcote RR, Kadin M, et al. Primary mediastinal large cell lymphoma in children: a report from the childrens cancer group. Pediatr Pathol Lab Med. 1995;15:561–70.

    CAS  PubMed  Google Scholar 

  37. Carr TF, Lockwood L, Stevens RF, Morris-Jones PH, Lewis I, DaCosta PE, et al. Childhood B cell lymphomas arising in the mediastinum. J Clin Pathol. 1993;46:513–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Dunleavy K. Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies. Hematology. 2017;2017:298–304.

    PubMed  PubMed Central  Google Scholar 

  39. Ahn HJ, Yoon DH, Kim S, Lee K, Kang E, Huh J, et al. Primary mediastinal large B-cell lymphoma: a single center experience in Korea. Blood Res. 2014;49:36–41.

    PubMed  PubMed Central  Google Scholar 

  40. Fiascone S, Datkhaeva I, Winer ES, Rizak T. Primary mediastinal large B-cell lymphoma in pregnancy. Leuk Lymphoma. 2016;57:240–3.

    PubMed  Google Scholar 

  41. Pileri S, Zinzani PL, Gaidano G, Falini B, Gaulard P, Zucca E, et al. Pathobiology of primary mediastinal B-cell lymphoma. Leuk Lymphoma. 2003;44(supplement 3):S21–6.

    CAS  PubMed  Google Scholar 

  42. Lazzarino M, Orlandi M, Paulli M, Sträter J, Klersy C, Gianelli U, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol. 1997;15:1646–53.

    CAS  PubMed  Google Scholar 

  43. Zinzani PL, Martelli M, Magagnoli M, Pescarmona E, Scaramucci L, Palombi F, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regime and mediastinal radiotherapy monitored by 67Gallium scan in 50 patients. Blood. 1999;94:3289–93.

    CAS  PubMed  Google Scholar 

  44. Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, et al. Primary mediastinal large B-cell lymphoma (PMBCL): long term results from a retrospective multicenter Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer. 2004;90:372–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Broccoli A, Casadei B, Stefoni V, Pellegrini C, Quirini F, Tonialini L, et al. The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients. BMNC Cancer. 2017;17:276–83.

    Google Scholar 

  46. Giulino-Roth L, O'Donohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, et al. Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol. 2017;179:739–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Pillon M, Carraro E, Mussolin L, Conter V, Tondo A, Aricò M, et al. Primary mediastinal large B-cell lymphoma: outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20. Pediatr Blood Cancer. 2018;65:e26855.

    Google Scholar 

  48. Moller P, Lammler B, Eberlein-Gonska M, Feichter GE, Hofmann WJ, Schmitteckert H, et al. Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch [Pathol Anat]. 1986;409:79–92.

    CAS  Google Scholar 

  49. Suster S, Moran CA. Pleomorphic large cell lymphoma of the mediastinum. Am J Surg Pathol. 1996;20:224–32.

    CAS  PubMed  Google Scholar 

  50. Calaminici M, Piper K, Lee AM, Norton AJ. CD23 expression in mediastinal large B-cell lymphomas. Histopathology. 2004;45:619–24.

    CAS  PubMed  Google Scholar 

  51. Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol. 1999;112:241–7.

    CAS  PubMed  Google Scholar 

  52. Copie-Bergman C, Gaulard P, Maouche-Chretien L, Brière J, Haioun C, Alonso MA, et al. The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood. 1999;94:3567–75.

    CAS  PubMed  Google Scholar 

  53. Tsang P, Cesarman E, Chadburn A, Liu YF, Knowles DM. Molecular characterization of primary mediastinal B-cell lymphoma. Am J Pathol. 1996;148:2017–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E, et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB1, and PU.1 in the absence of immunoglobulins. Am J Pathol. 2003;162:243–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin’s lymphoma. Blood. 2003;102:3871–9.

    CAS  PubMed  Google Scholar 

  56. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Joos S, Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood. 1996;87:1571–8.

    CAS  PubMed  Google Scholar 

  58. Wang Z, Cook JR. PDCD1LG2 (PD-L2) RNA in situ hybridization is a sensitive specific, and practical marker of primary mediastinal large B-cell lymphoma. Br J Haematol. 2018;181(4):564–6.

    PubMed  Google Scholar 

  59. Garcia JF, Mollejo M, Fraga M, Forteza J, Muniesa JA, Pérez-Guillermo M, et al. Large B-cell lymphoma with hodgkin’s features. Histopathology. 2005;47:101–10.

    CAS  PubMed  Google Scholar 

  60. Gomez-Gelvez JC, Smith LB. Reed-Sternberg-like cells in non-Hodgkin’s lymphoma. Arch Pathol Lab Med. 2015;139:1205–10.

    CAS  PubMed  Google Scholar 

  61. Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin’s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29:1141–421.

    Google Scholar 

  62. Oschlies I, Burkhardt B, Salaverria I, Rosenwald A, d’Amore ES, Szczepanowski M, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphomas in children. Haematologica. 2011;96:262–8.

    PubMed  Google Scholar 

  63. Dunleavy K. Management of primary mediastinal B-cell lymphoma and gray zone lymphoma. Oncology. 2017;6:499–501.

    Google Scholar 

  64. Salama M, Mariappan MR, Inamdar K, Tripp SR, Perkins SL. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin’s lymphoma. Int J Surg Pathol. 2010;18:121–8.

    PubMed  Google Scholar 

  65. Hoeller S, Zihler D, Zlobec I, Obermann EC, Pileri SA, Dirnhofer S, et al. BOB.1, CD79a, and cyclin E are the most appropriate markers to discriminate classical Hodgkin’s lymphoma from primary mediastinal large B-cell lymphoma. Histopathology. 2010;56:217–28.

    PubMed  Google Scholar 

  66. Etienne B, Guillaud PH, Loire R, Coiffier B, Berger F, Cordier JF. Aggressive primary mediastinal non-Hodgkin’s lymphomas: a study of 29 cases. Eur Respir J. 1999;13:1133–8.

    CAS  PubMed  Google Scholar 

  67. Gonin J, Kadiri H, Bensaci S, Le Tourneau A, Molina TJ, Diebold J, et al. Primary mediastinal anaplastic alk-2-positive large cell lymphoma of T/NK-cell type expressing CD20. Virchows Arch. 2007;450:355–8.

    CAS  PubMed  Google Scholar 

  68. Isaacson PG, Chan JKC, Tang C, Addis BJ. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. A thymic lymphoma mimicking myoepithelial sialadenitis. Am J Surg. 1990;14:342–51.

    CAS  Google Scholar 

  69. Nagasaka T, Lai R, Harada T, Chen YY, Chen WG, Arber DA, et al. Coexisting thymic and gastric lymphomas of mucosa-associated lymphoid tissues in a patient with Sjogren’s syndrome. Arch Pathol Lab Med. 2000;124:770–3.

    CAS  PubMed  Google Scholar 

  70. Moriyama E, Yokose T, Kodama T, Matsuno Y, Hojo F, Takahashi K, et al. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the thymus of a patient with pulmonary amyloid nodules. Jpn J Clin Oncol. 2000;30:349–53.

    CAS  PubMed  Google Scholar 

  71. Kamimura K, Nakamura N, Ishibashi T, Maruyam Y, Abe M. Somatic hypermutation of immunoglobulin heavy chain variable region genes in thymic marginal zone B-cell lymphoma of MALT type of a patient with Sjogren’s syndrome. Histopathology. 2002;40:292–304.

    Google Scholar 

  72. Sunada K, Hasegawa Y, Kodama T, Anami Y, Satoh H, Ohtsuka M, et al. Thymic and pulmonary mucosa-associated lymphoid tissue lymphomas in a patient with Sjogren syndrome and literature review. Respirology. 2007;12:144–7.

    PubMed  Google Scholar 

  73. Yamada S, Tadasu K, Mingyon M, Yoshiaki A, Noriko M. Mucosa-associated lymphoid tissue lymphoma of the thymus resected using combined thoracoscopic and transcervical approaches. Ann Thorac Surg. 2003;76:293–5.

    PubMed  Google Scholar 

  74. Kim JM. Primary extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type in the thymus of a patient with Sjogren’s syndrome and rheumatoid arthritis. J Korean Med Sci. 2003;18:897–900.

    PubMed  PubMed Central  Google Scholar 

  75. Kuroki S, Nasu K, Murakami K, Hayashi T, Sekiguchi R, Nishida H, et al. Thymic MALT lymphoma MR imaging findings and their correlation with histopathological findings on four cases. J Clin Imaging. 2004;28:272–7.

    Google Scholar 

  76. Ortone N, Copie-Bergman C, Remy P, Delfau-Larue MH, Alonso MA, Mariette X, et al. Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement. Virchows Arch. 2005;446:189–93.

    Google Scholar 

  77. Nakamura S, Koshikawa T, Kaba S, Tokoro Y, Suchi T, Kurita S. Imprint cytology of low-grade B-cell lymphoma of mucosa-associated lymphoid tisdsue arising in the thymus: a case report. Diagn Cytopathol. 1993;9:665–7.

    CAS  PubMed  Google Scholar 

  78. Takagi N, Nakamura S, Yamamoto K, Kunishima K, Takagi I, Suyama M, et al. Malignant lymphoma of mucosa-associated lymphoid tissue arising in the thymus of a patient with Sjogren’s syndrome. Cancer. 1992;69:1347–55.

    CAS  PubMed  Google Scholar 

  79. Parrens M, Dubus P, Danjoux M, Jougon J, Brousset P, Velly JF, et al. Mucosa-associated lymphoid tissue of the thymus. Hyperplasia vs lymphoma. Am J Clin Pathol. 2002;117:51–6.

    PubMed  Google Scholar 

  80. Inagaki H, Chan JKC, Ng JWM, Okabe M, Yoshino T, Okamoto M, et al. Primary thymic extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol. 2002;160:1435–43.

    PubMed  PubMed Central  Google Scholar 

  81. Shimizu K, Ishii G, Nagai K, Yokose T, Ishizawa K, Tamaru J, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in the thymus: report of four cases. Jpn J Clin Oncol. 2005;35:412–6.

    PubMed  Google Scholar 

  82. Sunohara M, Hara K, Osamura K, Tashiro N, Shibuya H, Nakahara K, et al. Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18. Intern Med. 2009;48:2025–32.

    PubMed  Google Scholar 

  83. Kitai R, Sasaki M, Sato K, Kubota T, Takeuchi H, Imamura Y. Thymic mucosa-associated lymphoid tissue lymphoma associated with bilateral orbital pseudotumor. Gen Thorac Cardiovasc Surg. 2009;57:566–9.

    PubMed  Google Scholar 

  84. Sakamoto T, Yamashita K, Mizumoto C. MALT lymphoma of the thymus with Sjogren’s syndrome: biphasic changes in serological abnormalities over a 4-year period following thymectomy. Int J Hematol. 2009;89:709–13.

    CAS  PubMed  Google Scholar 

  85. Maeda A, Hayama M, Nakata M, Masaki H, Tanemoto K. Mucosa associated lymphoid tissue lymphoma in the thymus of a patient with systemic lupus erythematosus. Gen Thorac Cardiovasc Surg. 2008;56:288–91.

    PubMed  Google Scholar 

  86. Kinoshita N, Ashizawa K, Abe K, Yamasaki N, Nakamura A, Tagawa T, et al. Mucosa-associated lymphoid tissue lymphoma of the thymus associated with Sjogren’s syndrome: report of a case. Surg Today. 2008;38:436–9.

    PubMed  Google Scholar 

  87. Harigae H, Ichinohasama R, Miura I, Kameoka J, Meguro K, Miyamura K, et al. Primary marginal zone lymphoma of the thymus accompanied by chromosomal anomaly 46,X,dup(X)(p11p22). Cancer Genet Cytogenet. 2002;133:142–7.

    CAS  PubMed  Google Scholar 

  88. Yamasaki S, Matsushita H, Tanimura S, Nakatani T, Hara S, Endo Y, et al. B-cell lymphoma of mucosa-associated lymphoid tissue of the thymus: a report of two cases with a background of Sjogren’s syndrome and monoclonal gammopathy. Hum Pathol. 1998;29:1021–4.

    CAS  PubMed  Google Scholar 

  89. McCluggage WG, McManus K, Qureshi R, McAleer S, Wotherspoon AC. Low-grade B-cell lymphoma of mucosa associated lymphoid tissue (MALT) of thymus. Hum Pathol. 2000;31:255–9.

    CAS  PubMed  Google Scholar 

  90. Lorsbach RB, Pinkus GS, Shahsafaei A, Dorfman DM. Primary marginal zone lymphoma of the thymus. Am J Clin Pathol. 2000;113:784–91.

    CAS  PubMed  Google Scholar 

  91. Weissferdt A, Moran CA. Primary MALT-type lymphoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Lung. 2011;189:461–6.

    CAS  PubMed  Google Scholar 

  92. Sternberg C. Leukosarcomatose and myeloblastenleukaamie. Beitr Pathol. 1916;61:75.

    Google Scholar 

  93. Cooke JV. Mediastinal tumor in acute leukemia. A clinical and roentgenologic study. Am J Dis Child. 1932;44:1153.

    Google Scholar 

  94. Smith JL, Clein GP, Barker CR, Collins RD. Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin. Lancet. 1973;1:74.

    CAS  PubMed  Google Scholar 

  95. Barcos MGP, Lukes RJ. Malignant lymphoma of the convoluted lymphocytes. A new entity of possible T-cell type. In: Sinks L, Godden J, editors. Conflicts in childhood Cancer: an evaluation of current management. New York: Liss; 1975. p. 147.

    Google Scholar 

  96. Nathwani BN, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic: a clinicopathologic study of 95 patients. Cancer. 1976;48:2347.

    Google Scholar 

  97. Borowitz MJ, Falletta JM. Leukemias and lymphomas of thymic differentiation. Clin Lab Med. 1988;8:119–34.

    CAS  PubMed  Google Scholar 

  98. Cortelazzo S, Ponzoni M, Ferreri AJM, Hoelzer D. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2011;79:330–43.

    PubMed  Google Scholar 

  99. Han X, Kilfoy B, Zheng T, Holford TR, Zhu C, Zhu Y, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control. 2008;19:841–58.

    PubMed  Google Scholar 

  100. Swerdlow SH, Campo E, Harris N, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC; 2008.

    Google Scholar 

  101. Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol. 2015;96:447–60.

    Google Scholar 

  102. Portell CA, Sweetenham JW. Adult lymphoblastic lymphoma. Cancer J. 2012;18:432–8.

    CAS  PubMed  Google Scholar 

  103. Le Gouill S, Lepretre S, Briere J, Morel P, Bouabdallah R, Raffoux E, et al. Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials. Leukemioa. 2003;17:2220–4.

    Google Scholar 

  104. Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304–17.

    PubMed  Google Scholar 

  105. Mlika M, Khanfir D, Mansouri R, El-Mezni F. Multivariate analysis of prognostic factors of lymphoblastic lymphomas of the mediastinum. Ann Hematol. 2016;95:1731–2.

    PubMed  Google Scholar 

  106. Thomas DA, Kantarjian HM. Lymphoblastic lymphoma. Hematol Oncol Clin North Am. 2001;15:51–95.

    CAS  PubMed  Google Scholar 

  107. Schwartz EE, Conroy JF, Bonner H. Mediastinal involvement in adults with lymphoblastic lymphoma. Acta Radiol. 1987;28:403–7.

    CAS  PubMed  Google Scholar 

  108. Macon WR, Rynalski TH, Swedlow SH, Cousar JB. T-cell lymphoblastic leukemia/lymphoma presenting in a recurrent thymoma. Mod Pathol. 1991;4:524–8.

    CAS  PubMed  Google Scholar 

  109. Liu KL, Herbrecht R, Tranchant C, Gasser B, Warter JM, Wihlm JM, et al. Malignant thymic lymphoblastic lymphoma and myasthenia gravis: an exceptional association. Nouv Rev Fr Hematol. 1992;34:221–3.

    CAS  PubMed  Google Scholar 

  110. Posner MR, Said J, Pinkus GS, Nadler LM, Hardy R, Flatow F, et al. T-cell lymphoblastic lymphoma with subsequent acute nonlymphocytic leukemia. Cancer. 1982;50:118–24.

    CAS  PubMed  Google Scholar 

  111. Hvizdala EV, Berard C, Callihan T, Falletta J, Sabio H, Shuster JJ, et al. Lymphoblastic lymphoma in children –a randomized trial comparing LSA2 L2 with the A-COP+ therapeutic regime: a pediatric oncology group study. J Clin Oncol. 1988;6:26–33.

    CAS  PubMed  Google Scholar 

  112. Patte C, Kalifa C, Flamant F, Hartmann O, Brugières L, Valteau-Couanet D, et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol. 1992;20:105–13.

    CAS  PubMed  Google Scholar 

  113. Sander CA, Jaffe ES, Gebhardt FC, Yano T, Medeiros LJ. Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol. 1992;16:300–5.

    CAS  PubMed  Google Scholar 

  114. Manning JT, Pugh WC, El-Naggar A, Ordonez NG. Mediastinal lymphoblastic lymphoma with non-lymphoblastic histologic features. Mod Pathol. 1994;7:59–63.

    PubMed  Google Scholar 

  115. Sweetenham JW. Lymphoblastic lymphoma in adults. Curr Hematol Malig Rep. 2006;1:241–7.

    PubMed  Google Scholar 

  116. Dawson PJ. The original illustrations of Hodgkin’s disease. Ann Diagn Pathol. 1999;3:386–93.

    CAS  PubMed  Google Scholar 

  117. Aisenberg AC. Historical review. Br J Haematol. 2000; 109:466–76.

    CAS  PubMed  Google Scholar 

  118. Dawson PJ. Whatever happened to Dorothy reed? Ann Diagn Pathol. 2003;7:195–203.

    PubMed  Google Scholar 

  119. Reed DM. On the pathological changes in Hodgkin’s disease, with especial reference to its relation to tuberculosis. Johns Hopkins Rep. 1902;10:113–96.

    Google Scholar 

  120. Jackson H, Parker F. Hodgkin’s disease.VI. Clinical diagnosis. NEJM. 1946;234:37–41.

    PubMed  Google Scholar 

  121. Tsang RW, Hodgson DC, Crump M. Hodgkin’s lymphoma. Curr Probl Cancer 2006;30:107–58.

    PubMed  Google Scholar 

  122. Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang J-S, et al. Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. NEJM. 2003;349:1324–32.

    CAS  PubMed  Google Scholar 

  123. Piña-Oviedo S, Moran CA. Primary mediastinal classical Hodgkin’s lymphoma. Adv Anat Pathol. 2016;23(5):285–309.

    PubMed  Google Scholar 

  124. Katz A, Lattes R. Granulomatous thymoma or Hodgkin’s disease of the thymus. Cancer. 1969;23:1–15.

    CAS  PubMed  Google Scholar 

  125. Fechner RE. Hodgkin’s disease of the thymus. Cancer. 1969;1:16–23.

    Google Scholar 

  126. Keller AR, Castleman B. Hodgkin’s disease of the thymus gland. Cancer. 1974;33:1615–23.

    CAS  PubMed  Google Scholar 

  127. Smetana HF, Cohen BM. Mortality in relation to histologic type of Hodgkin’s disease. Blood. 1956;11:211–24.

    CAS  PubMed  Google Scholar 

  128. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin’s disease. Cancer Res. 1966;26:1063–81.

    CAS  PubMed  Google Scholar 

  129. MacLennan KA, Bennett MH, Tu A, Hudson BV, Easterling MJ, Hudson GV, et al. Relatioship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin’s disease. A study of 1659 patients. Cancer. 1989;64:1686–93.

    CAS  PubMed  Google Scholar 

  130. Ferry JA, Linggood RM, Convery KM, Efird JT, Eliseo R, Harris NL. Hodgkin’s disease, nodular sclerosis type. Implications of histologic subclassification. Cancer. 1993;71:457–63.

    CAS  PubMed  Google Scholar 

  131. Hess JL, Bodis S, Pinkus G, Silver B, Mauch P. Histopathologic grading of nodular sclerosis Hodgkin’s disease. Lack of prognosticd significance in 254 surgically staged patients. Cancer. 1994;74:708–14.

    CAS  PubMed  Google Scholar 

  132. Heron CW, Husband JE, Williams MP. Hodgkin disease: CT of the thymus. Radiology. 1988;167:647–51.

    CAS  PubMed  Google Scholar 

  133. Priola AM, Priola SM. Primary mediastinal Hodgkin lymphoma and rebound thymic hyperplasia: differentiation with chemical-shift magnetic resonance imaging after treatment. Int J Haematol. 2009;90:8–10.

    Google Scholar 

  134. Schmid C, Pan L, Diss T, Isaacson PG. Expression of B-cell antigens by Hodgkin’s and reed-Sternberg cells. Am J Pathol. 1991;139:701–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  135. Harris JA, Jain S, Ren Q, Zarineh A, Liu C, Ibrahim S. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin’s lymphoma. Diagn Pathol. 2012;7:12–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  136. Kupper R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, et al. Hodgkin disease: Hodgkin and reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B-cells at various stages of development. Proc Natl Acad Sci. 1994;91:10962–6.

    Google Scholar 

  137. Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and reed-Sternberg cells in Hodgkin’s disease represents the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495–505.

    CAS  PubMed  Google Scholar 

  138. Kuppers R, Hansmann ML. The Hodgkin and Reed/Sternberg cell. Int J Biochem Cell Biol. 2005;37:511–7.

    PubMed  Google Scholar 

  139. Kuppers R. The biology of Hodgkin’s lymphoma. Nat Rev Cancer. 2009;9:15–27. https://doi.org/10.1038/nrc2542.

    Article  CAS  PubMed  Google Scholar 

  140. Monda L, Warnke R, Rosai J. A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases. Am J Pathol. 1986;122:562–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  141. Le BE, Korst RJ, Taskin M. Right pneumonectomy for resection of a posterior mediastinal follicular dendritic cell sarcoma arising from Castleman’s disease. Ann Thorac Surg. 2014;97:e101–3.

    Google Scholar 

  142. Hu J, Dong D, Jiang Z, Hu H. Clinicopathological characgteristics of mediastinal follicular dendritic cell sarcoma: report of three cases. J Cardiothorac Surg. 2016;11:56–9.

    PubMed  PubMed Central  Google Scholar 

  143. Viola P, Vroobel KM, Devaraj A, Jordan S, Ladas G, Dusmet M, et al. Follicualr dendritic cell tumour/sarcoma: a commonly misdiagnosed tumour in the thorax. Histopathology. 2016;69:752–61.

    PubMed  Google Scholar 

  144. Hartert M, Strobel P, Dahm M, Nix W, Marx A, Vahl CF. A follicular dendritic cell sarcoma of the mediastinum with immature T-cells and association with myasthenia gravis. Am J Surg Pathol. 2010;34:742–5.

    PubMed  Google Scholar 

  145. Jiang L, Admirand JH, Moran CA, Ford RJ, Bueso-Ramos CE. Mediastinal follicular dendritic cell sarcoma with involving bone marrow: a case report and review of the literature. Ann Diagn Pathol. 2006;10:357–62.

    PubMed  Google Scholar 

  146. Gupta RM, Roy DC, Gupta IM, Khanna S. Extramedullary plasmacytoma IgG type I presenting as mediastinal syndrome. Br J Dis Chest. 1974;68:65.

    CAS  PubMed  Google Scholar 

  147. Arbona GL, Loyd TV, Lucas J. Mediastinal extramedullary plasmacytoma. South Med J. 1981;73:670.

    Google Scholar 

  148. Moran CA, Suster S, Fishback NF, Koss MN. Extramedullary plasmacytoma presenting as mediastinal masses: clinicoparthologic study of two cases preceding the onset of multiple myeloma. Mod Pathol. 1995;8:257–9.

    CAS  PubMed  Google Scholar 

  149. Ahmed R, Marchbank AJ, Nicholson AG, Wotherspoon AC, Ladas GP. Extramedullary plasmacytoma presenting with myasthenia gravis and mediastinal mass. Ann Thorac Surg. 2000;70:1390–2.

    CAS  PubMed  Google Scholar 

  150. Lee SY, Kim JH, Shin JS, Shin C, In KH, Kang KH, et al. A case of extramedullary plasmacytoma arising from the posterior mediastinum. Korean J Intern Med. 2005;20:173–6.

    PubMed  PubMed Central  Google Scholar 

  151. Wetherbe ER, Dincer HE. IgG myeloma presenting as a large mediastinal mass and pleural effusion. J Bronchology Interv Pulmonol. 2012;19:65–7.

    Google Scholar 

  152. Sato K, Fumimoto S, Fukada T, Chihashi Y, Ochi K, Satomi H, et al. Extramedullary plasmacytoma arising from the anterior mediastinum. Ann Thorac Surg. 2017;103:e393–5.

    PubMed  Google Scholar 

  153. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956;9:822–30.

    CAS  PubMed  Google Scholar 

  154. Inada K, Kawai K, Katsumura T, Nakano A. Giant lymph node hyperplasia if mediastinum: case report with review of literature. Am Rev Resp Dis. 1959;79:232–7.

    CAS  Google Scholar 

  155. Katz I, Dziadiw R. Localized mediastinal lymph node hyperplasia: report of case with roentgen findings simulating porterior mediastinal neurofibroma. Am J Roentgenol Radium Ther Nucl Med. 1960;84:206–12.

    CAS  PubMed  Google Scholar 

  156. Wolfel DA, Antonius JI, Cowley A. Posterior mediastinal lymph node hyperplasia. Am J Roentgenol. 1964;91:120–4.

    CAS  Google Scholar 

  157. Lattes R, Pachter M. Benign lymphoid masses of probable hamatomatous nature: analysis of 12 cases. Cancer. 1962;15:197–214.

    CAS  PubMed  Google Scholar 

  158. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670–83.

    CAS  PubMed  Google Scholar 

  159. Karcher DS, Pearson CE, Butler WM, Hurwitz MA, Cassell PF. Giant lymph node hyperplasia involving the thymus with associated nephrotic syndrome and myelofibrosis. Am J Clin Pathol. 1982;77:100–4.

    CAS  PubMed  Google Scholar 

  160. Regal MAH, Aljehani YM, Bousbalt H. Primary mediastinal Castleman’s disease. Rare Tumors. 2010;2:e11.

    PubMed  PubMed Central  Google Scholar 

  161. Shah S, Shah S. Posterior mediastinal Castleman’s disease: a case report. Indian J Surg Oncol. 2010;1:343–5.

    PubMed  Google Scholar 

  162. Ishikawa K, Kato T, Aragaki M, Ohbuchi T, Kimura S, Matsui Y, et al. A case of Castleman’s disease with myasthenia gravis. Ann Thorac Cardiovasc Surg. 2014;20(supplement):585–8.

    PubMed  Google Scholar 

  163. Kim CH, Jeong JS, Kim SR, Choe YH, Park HS, Lee YC. Coexistence of mediastinal Caatleman’s disease with spindle cell carcinoma of the lung. Am J Respir Crit Care Med. 2017;196:652–4.

    PubMed  Google Scholar 

  164. Yu JY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, et al. Castleman’s disease presenting as a tracheal mass. Ann Thorac Surg. 2014;97:1798–800.

    PubMed  Google Scholar 

  165. Hussein H, Khawar M, Cherry M, Youness H. Castleman’s disease presenting as a mediastinal mass: mimicker of malignancy. Am J Med. 2016;129:e67–8.

    PubMed  Google Scholar 

  166. Paci M, Valli R, Renconi S, Sgarbi G. Mediastinal Castleman’s disease mimicking thoracic paravertebral schwannoma. Interact Cardiovasc Thorac Surg. 2011;13:346–7.

    PubMed  Google Scholar 

  167. Aoki M, Otsuka T, Yanagi M, Yokomakura N, Nagata T, Nakamura Y, et al. A case of resected plasma cell type of Castleman’s disease with intramediastinal lymph node spread. Ann Thorac Cardiovasc Surg. 2014;20(supplement):682–5.

    PubMed  Google Scholar 

  168. Nistor C, Davidescu M, Giuche A, Bluoss C, Motaş N, Motaş C, et al. A rare case of unicentric plasma cell type Castleman’s disease in the mediastinum. Pneumologia. 2010;59:32–5.

    PubMed  Google Scholar 

  169. Haro A, Kuramitsu E, Fukuyama Y. Complete resection of unicentric Castleman disease in the superior mediastinum: a case report. Int J Surg Case Rep. 2016;25:44–7.

    PubMed  PubMed Central  Google Scholar 

  170. Slater B, Nordin AB, Allen CE, Elghetany MT, Heinle JS, Kim ES. Resection of mediastinal Castleman’s disease: a case report. Pediatr Hematol Oncol. 2013;30:554–6.

    PubMed  Google Scholar 

  171. Lorenz JM, Zangan SM, Leef JA. Mediastinal Castleman’s disease: embolization without surgery. J Vasc Interv Radiol. 2009;20:1393–4.

    PubMed  Google Scholar 

  172. Hountis P, Dedeilias P, Douzinas M. The management of Castleman’s disease of the mediastinum: a case report. Cases J. 2008;1:330.

    PubMed  PubMed Central  Google Scholar 

  173. Fajgenbaum DC, Shilling D. Castleman disease pathogenesis. Hematol Oncol N Am. 2018;32:11–21.

    Google Scholar 

  174. Parravinci C, Coprbellino M, Pauli M, Magrini U, Lazzarino M, Moore PS, et al. Expression of a virus-derived cytokine, KSHV vL-6, in HIV seronegative Castleman’s disease. Am J Pathol. 1997;151:1517–22.

    PubMed Central  Google Scholar 

  175. Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematol Oncol Clin N Am. 2018;32:37–52.

    Google Scholar 

  176. Simpson D. Epidemiology of Castleman disease. Hematol Oncol Clin N Am. 2018;32:1–10.

    Google Scholar 

  177. Van Rhee F, Greenway A, Stone K. Treatment of idiopathic Castleman disease. Hematol Oncol Clin N Am. 2018;32:89–106.

    Google Scholar 

  178. Szalat R, Munshi NC. Diagnosis of Castleman disease. Hematol Oncol Clin N Am. 2018;32:53–64.

    Google Scholar 

  179. Knoblich R. Extramedullary hematopoiesis presenting as intrathoracic tumors. Report of a case in a patient with thalassemia minor. Cancer. 1960;13:462–8.

    Google Scholar 

  180. Da Costa JL, Loh YS, Hanam E. Extramedullary hemopoiesis with multiple tumor-simulating mediastinal masses in hemoglobin E-thalasemia disease. Chest. 1974;65:210–2.

    PubMed  Google Scholar 

  181. Cantinella FP, Boyd AD, Spencer FC. Intrathoracic extramedullary hematopoiesis simulating anterior mediastinal tumor. J Thorac Cardiovasc Surg. 1985;89:580–4.

    Google Scholar 

  182. Verani R, Olson J, Moake JL. Intrathoracic extramedullary hematopoiesis. Report of a case in a patient with sickle-cell disease –beta-thalasemia. Am J Clin Pathol. 1980;73:133–7.

    CAS  PubMed  Google Scholar 

  183. Krag D, Reich S. Heteropic marrow (myelolipoma) of the mediastinum. Chest. 1972;61:514.

    CAS  PubMed  Google Scholar 

  184. Covey GW. Erythroblastosis: report of a cases presenting erythroblastic tumor in thoracic cavity. Am J Pathol. 1935;11:551.

    CAS  PubMed  PubMed Central  Google Scholar 

  185. Hanford RB, Schneider GP, McCarthy JD. Massive thoracic extramedullary hematopoiesis. N Engl J Med. 1960;263:120.

    CAS  PubMed  Google Scholar 

  186. Andras C, Lassen KP, Holaday WJ. Tumor simulating intrathoracic extramedullary hematopoiesis. Ann Thorac Surg. 1970;10:75.

    CAS  PubMed  Google Scholar 

  187. Condon WB, Safarik LR, Elzi EP. Extramedullary hematopoiesis simulating intra-thoracic tumor. Arch Surg. 1965;90:643.

    CAS  PubMed  Google Scholar 

  188. Foster JBT. Primary thoracic myelolipoma: case report. AMA Arch Pathol. 1958;65:295.

    CAS  PubMed  Google Scholar 

  189. Varizi M, Sadeghipour A, Pazooki A, Shoolami LZ. Primary mediastinal myelolipoma. Ann Thorac Surg. 2008;85:1805–6.

    Google Scholar 

  190. Loh CK, Alcorta C, McElhinney J. Extramedullary hematopoiesis simulating posterior mediastinal tumors. Ann Thorac Surg. 1996;61:1003–5.

    CAS  PubMed  Google Scholar 

  191. Moran CA, Suster S, Fishback N, Koss MN. Extramedullary hematopoiesis presenting as posterior mediastinal mass: a study of four cases. Mod Pathol. 1995;8:249–51.

    CAS  PubMed  Google Scholar 

  192. Albert S, Wolf PL, Pryjma I, Vasquez J. Erythropoiesis in the human thymus. Am J Clin Pathol. 1966;45:460–4.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neda Kalhor .

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kalhor, N., Moran, C. (2019). Lymphoproliferative Disorders. In: Mediastinal Pathology . Springer, Cham. https://doi.org/10.1007/978-3-319-98980-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98980-8_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98979-2

  • Online ISBN: 978-3-319-98980-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics